Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.

Blood - 4 Nov 2010

Fielding Adele K

Abstract excerpt

The Philadelphia chromosome is present in approximately 20% to 30% of adults with acute lymphoblastic leukemia (ALL). The poor prognosis of this relatively uncommon acute leukemia has led to the rapid adoption of treatment strategies such as unrelated donor hematopoietic stem cell transplant and tyrosine kinase inhibitors into clinical practice, despite a relative paucity of randomized clinical trials. Recently,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to Central Nervous System Neoplasms
Share to Dasatinib

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Fusion Proteins, bcr-abl

Share to Imatinib Mesylate

Share to Philadelphia Chromosome

Share to Remission Induction

Share to Thiazoles

Source

Identifiers

PMID: 20656928
DOI: 10.1182/blood-2010-01-242750

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.PMID 20656928Read ↗

How I treat Philadelphia chromosome–positive acute lymphoblastic leukemiaSemantic proximity Read ↗

How we approach Philadelphia chromosome‐positive acute lymphoblastic leukemia in children and young adultsSemantic proximity Read ↗

How I treat Philadelphia chromosome–like acute lymphoblastic leukemia in children, adolescents, and young adultsSemantic proximity Read ↗

Treatment of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in Adults: A Broader Range of Options, Improved Outcomes, and More Therapeutic DilemmasSemantic proximity Read ↗

How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemiaSemantic proximity Read ↗

Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.Semantic proximity Read ↗

Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in AdultsSemantic proximity Read ↗

Treatment of Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Evidence-Based Minireview: What is the optimal tyrosine kinase inhibitor for adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia?Semantic proximity Read ↗

How I treat T-cell acute lymphoblastic leukemia in adults.Semantic proximity Read ↗

Current management of Philadelphia chromosome positive ALL and the role of stem cell transplantationSemantic proximity Read ↗

Integrative Insights into Philadelphia-like B-Cell Acute Lymphoblastic Leukemia: A Genetic and Molecular LandscapeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.